The Treatment of Meniere's Disease by Acupuncture

1983 ◽  
Vol 11 (01n04) ◽  
pp. 102-105 ◽  
Author(s):  
Antun Steinberger ◽  
Mihovil Pansini
Keyword(s):  
Acupuncture Treatment ◽  
Hearing Threshold ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
The Other ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Hearing Level ◽  
Menière's Disease ◽  
Ménière's Disease

34 patients suffering from Meniere's disease were treated by acupuncture. Prior to acupuncture most of them had been treated with various other medical means without satisfactory results. After acupuncture treatment their condition greatly improved. The classic symptoms of Meniere's disease are vertigo, tinnitus and deafness, but for all the treated patients vertigo was the most uncomfortable and distressing symptom. In all our cases vertigo stopped after a few acupuncture courses; but in our opinion it is more important to follow and control hearing threshold, since if it remains stable the other symptoms of Meniere's disease also do not persist. All our patients were regularly followed by careful audiometric studies several years after acupuncture treatment. In most cases hearing level had not greatly varied, so the other symptoms of Meniere's disease were not present in any large degree.

Transtympanic dexamethasone application in Ménière's disease: an alternative treatment for intractable vertigo

1999 ◽  
Vol 113 (3) ◽  
pp. 217-221 ◽  
Author(s):  
Levent Sennaroğlu ◽  
Farzin Mottaghian Dini ◽  
Gonca Sennaroğlu ◽  
Bulent Gursel ◽  
Soner Ozkan
Keyword(s):  
Topical Treatment ◽  
Good Alternative ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Topical Steroids ◽  
Hearing Level ◽  
Menière's Disease ◽  
Ménière's Disease

AbstractThe aetiology of Ménière's disease still remains unknown and its therapy is therefore empirical. As a result of immunological abnormalities demonstrated, steroids are commonly used in Ménière's disease. The place of topical steroids is still controversial. In this investigation topical dexamethasone is applied for three months through a ventilation tube in patients with intractable vertigo. The results showed that this treatment controls vertigo in 72 per cent of cases. No patient was worse than before treatment. Only in 17 per cent of the patients was there an increase in hearing level. When compared to the reports which used only tympanostomy tubes, this procedure seems to have a placebo effect with minimal harmful effects. It appears that transtympanic dexamethasone application is a good alternative to vestibular nerve section. Topical treatment may be sufficient in most patients. Systemic treatment may be used in patients where topical treatment fails.

Relationship between hearing threshold at the affected and unaffected ear in unilateral Meniere’s disease

2015 ◽  
Vol 273 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Roberto Albera ◽  
Andrea Canale ◽  
Claudia Cassandro ◽  
Andrea Albera ◽  
Azia Maria Sammartano ◽  
...  
Keyword(s):  
Hearing Threshold ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Menière's Disease ◽  
Ménière's Disease

scholarly journals Positional Nystagmus after Acute Vertiginous Attack in Meniere’s Disease

2021 ◽  
Vol 11 (1) ◽  
pp. 55-62
Author(s):  
Haemin Noh ◽  
Dong-Han Lee ◽  
Jung Eun Shin ◽  
Chang-Hee Kim
Keyword(s):  
Inner Ear ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
The Other ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Positional Nystagmus ◽  
Menière's Disease ◽  
Ménière's Disease ◽  
Paroxysmal Positional Vertigo

There have been no reports regarding nystagmus observed immediately after the end of an acute vertiginous attack in patients with Meniere’s disease. The aim of this study was to demonstrate positional direction-changing nystagmus in patients with Meniere’s disease, and to discuss the mechanism that underlies this nystagmus. Video-nystagmography was recorded in two patients with definite Meniere’s disease, who showed positional direction-changing nystagmus during the period immediately after a vertigo attack. In one patient, video-nystagmographic recording was conducted 5 h after an episode of vertigo attack, and it showed very weak, persistent positional geotropic direction-changing nystagmus. In the other patient, video-nystagmographic recording was conducted 23 h after an episode of vertigo attack, and it showed very weak, persistent positional apogeotropic direction-changing nystagmus. Our patients exhibited very weak, persistent positional direction-changing nystagmus, which was geotropic in one and apogeotropic in the other. This type of positional nystagmus has been reported in other inner ear disorders and it cannot be clearly explained by typical benign paroxysmal positional vertigo. The change in chemical composition and/or electrolyte concentration of the inner ear fluid, although still unclear, may underlie the production of this characteristic nystagmus in these patients.

scholarly journals New possibilities in the treatment of Meniere's disease

2002 ◽  
Vol 59 (1) ◽  
pp. 11-15
Author(s):  
Nada Milanovic ◽  
Boris Kitanoski ◽  
Boza Ristic ◽  
Violeta Jacimovic
Keyword(s):  
Vestibular Function ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
The Other ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Menière's Disease ◽  
Mild Degree ◽  
Intratympanic Gentamicin ◽  
Ménière's Disease

The results of the treatment of Meniere's disease by intratympanic instillation of gentamicin in 32 patients over a 24-months period were analyzed. The receded vestibular function was found in 96,8% patients whereas in the remaining 3,2% pronounced vestibular hypo function was observed. One month after the treatment vertiginous attacks disappeared in all the patients. However, three months after the treatment infrequent episodes of mild degree vertigo and mild unsteadiness that did not require additional intratympanic gentamicin application appeared in 15% of the patients with Meniere's disease. The vertiginous attacks ceased or were pronouncedly reduced in 85% of the patients. The unstable vestibular hypo function was successfully converted into stabilized, centrally compensated areflexia. Intratympanic gentamicin exerted better results than the other invasive therapies for intractable Meniere's disease.

Long-term efficacy of vestibular neurotomy in disabling Ménière’s disease and Tumarkin drop attacks

2022 ◽  
pp. 1-7
Keyword(s):  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Csf Leak ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Hearing Level ◽  
Menière's Disease ◽  
Drop Attacks ◽  
Ménière's Disease

OBJECTIVE When Ménière’s disease (MD) becomes disabling due to the frequency of attacks or the appearance of drop attacks (i.e., Tumarkin otolithic crisis) despite "conservative" medical and surgical treatments, a radical treatment like vestibular neurotomy (VN) is possible. An ideal MD treatment would relieve symptoms immediately and persist after the therapy. The aim of this study was to identify if VN was effective after 10 years of follow-up regarding vertigo and drop attacks, and to collect the immediate complications. METHODS The authors report a retrospective, single-center (i.e., in a single tertiary referral center with otoneurological surgery activity) cohort study conducted from January 2003 to April 2020. All patients with unilateral disabling MD who had received a VN with at least 10 years of follow-up were included. The therapeutic efficacy was defined by complete disappearance of vertigo and drop attacks. The postoperative complications (CSF leak, total deafness, meningitis, death) were determined immediately after the surgery, and the hearing thresholds were determined during the patient follow-up with the pure tone average (PTA). RESULTS A total of 74 patients (of 85 who were eligible), average age 51.9 ± 11.1 years, including 38 men (51.4%), with disabling MD and/or Tumarkin drop attacks (24.3%) received VN, with at least 10 years of follow-up after surgery. After an average follow-up of 12.4 ± 1.7 years (range 10.0–16.3 years), 67 patients (90.5%) no longer presented any vertiginous attacks, and no patient experienced drop attack. The mean variation in early pre- and postoperative PTA was not statistically significant (n = 64, 2.2 ± 10.3 decibels hearing level [range −18 to 29], 95% CI [−0.4 to 4.37]; p = 0.096), and 84.4% of the patients evaluated had unchanged or improved postoperative PTA. Three significant complications were noted, including two surgical revisions for CSF leak. There was no permanent facial paralysis, meningitis, or death. CONCLUSIONS In case of disabling MD (disabling vertigo refractory to conservative vestibular treatments—Tumarkin drop attacks), VN via the retrosigmoid approach must be the prioritized proposal in comparison to intratympanic gentamicin injections, because of the extremely low complication rate and the immediate and long-lasting effect of this treatment on vertigo and falls.

scholarly journals Intratympanic gentamicin injection in Ménière’s disease: our experience and outcomes

2020 ◽  
Author(s):  
Barbara Filosa ◽  
Antonio Trusio ◽  
Giuseppe Malafronte
Keyword(s):  
Pure Tone ◽  
Hearing Threshold ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Menière's Disease ◽  
Pure Tone Average ◽  
Intratympanic Gentamicin ◽  
Ménière's Disease

Title: Intratympanic gentamicin injection in Ménière’s disease: our twelve years’ experience and outcomes. Objective: The aim of our study is to evaluate the effectiveness of intratympanic gentamicin injection(ITG) on vertigo control with reduced doses and its hearing effects. Study design: Retrospective study Materials and Method: The study was conducted at our Otolaryngology Department of AORN “S.G. Moscati” between January 2005 and January 2015 on 72 patients with disabling unilateral Meniere’s disease treated with ITG. We use 0.2-0.3 mL of gentamicin sulfate at a concentration of 40mg/ml, injected into the affected ear through the posterior-inferior quadrant of the tympanic membrane. The procedure was carried out for three following days. Main outcome measures: vertigo control and hearing threshold changes after ITG treatment. Results: In the 98.6% of the patients (n=71) the ITG produced the full remission of the vertiginous symptoms. In the 91.6% of cases(n=66) a single treatment (three consequent injections) was sufficient to control vertigo, in the 5.5% of cases (n=4) two treatments were necessary to control vertigo and in the 1.3% of patients(n=1) three treatments were necessary to control vertigo. In no case we have had hearing loss after ITG procedure. The pre-treatment pure tone average was 48 db. The post-treatment pure tone average was 49.2 db. This difference was no statistical difference. Conclusion: In this study we reported high vertigo control, long follow-up and no case of significant hearing worsening. We consider the three injections in the following three days with low doses of gentamicin a safe and valid treatment for Meniere’s disease. Keyword : Meniere’s disease, intratympanic gentamicin injection, vertigo control, hearing worsening, aminoglycoside ototoxicity.

Rare cases of Ménière's disease in children

2006 ◽  
Vol 120 (4) ◽  
pp. 343-352 ◽  
Author(s):  
Y H Choung ◽  
K Park ◽  
C H Kim ◽  
H J Kim ◽  
K Kim
Keyword(s):  
Hearing Impairment ◽  
Hearing Threshold ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
High Tone ◽  
Menière's Disease ◽  
Number Of Patients ◽  
Ménière's Disease

Classical Ménière's disease is rarely found in children and literature regarding it is scarce. In general, the frequency of Ménière's disease in children is only 0.4–7.0 per cent of that in adults. The progression pattern of Ménière's disease in children is not known well. Here, we report three cases of Ménière's disease in children less than 15 years old, treated over nine years. The three cases comprise 14- and 13-year-old boys and a nine-year-old girl. Two of the three patients initially complained only of recurrent bouts of vertigo, without any tinnitus, ear fullness or hearing impairment. In all three cases, the early pure tone audiograms showed only high tone frequency loss, regardless of subjective hearing loss, and the decrease in the hearing threshold was observed one to eight years after the dizziness attacks began. The hearing threshold was usually decreased to a level of mild or moderate hearing impairment. After diuretic treatment, vertigo was generally well controlled, and some cases showed improvement in hearing. Of the total number of patients with Ménière's disease who visited our department over nine years, 2.6 per cent (3/114) were children, and the overall incidence of Ménière's disease in children with vertigo was 2.0 per cent (3/147). In conclusion, Ménière's disease in children rarely develops and may have characteristics of high tone loss in initial audiograms.

Effect of External Auditory Canal Pressure upon the Hearing Threshold in Patients with Meniere's Disease

1989 ◽  
Vol 108 (sup468) ◽  
pp. 87-92 ◽  
Author(s):  
Tetsuaki Kawase ◽  
Tomonori Takasaka ◽  
Jun Kusakari ◽  
Hideichi Shinkawa ◽  
Ryo Yuasa
Keyword(s):  
External Auditory Canal ◽  
Hearing Threshold ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Menière's Disease ◽  
Ménière's Disease
Sign in / Sign up

Export Citation Format

Share Document